Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial

Faster, Cleaner, Better.

Rock Creek Pharmaceuticals Inc (RCPIQ)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] by (Cboe BZX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]

Cash Flow for [[ item.sessionDateDisplayLong ]]

Fiscal Year End Date: 12/31

(Values in U.S. thousands)

	12-2000	12-1999	12-1998	12-1997	12-1996
Cash Flows From Operating Activities
Net Income	10,041	11,515	-4,190	N/A	N/A
Depreciation Amortization	2,269	784	960	N/A	N/A
Income taxes - deferred	2,966	-2,386	N/A	N/A	N/A
Accounts receivable	-1,873	-2,034	N/A	N/A	N/A
Accounts payable and accrued liabilities	-312	976	N/A	N/A	N/A
Other Working Capital	-2,716	9,433	60	N/A	N/A
Other Operating Activity	2,763	2,540	510	0	0
Operating Cash Flow	$13,139	$20,827	$-2,660	$N/A	$N/A

Cash Flows From Investing Activities
PPE Investments	-19,095	-10,208	-280	N/A	N/A
Purchase Sale Intangibles	-333	-241	N/A	N/A	N/A
Other Investing Activity	-333	-1,311	-40	0	0
Investing Cash Flow	$-19,428	$-11,520	$-320	$N/A	$N/A

Cash Flows From Financing Activities
Debt Issued	17,958	7,172	N/A	N/A	N/A
Debt Repayment	-522	-383	N/A	N/A	N/A
Common Stock Issued	N/A	1,046	N/A	N/A	N/A
Other Financing Activity	-11,605	-40	3,080	0	0
Financing Cash Flow	$5,830	$7,795	$3,080	$N/A	$N/A

Beginning Cash Position	17,205	103	10	N/A	N/A
End Cash Position	16,747	17,205	100	N/A	N/A
Net Cash Flow	$-459	$17,103	$90	$N/A	$N/A

Free Cash Flow
Operating Cash Flow	13,139	20,827	-2,660	N/A	N/A
Capital Expenditure	-19,100	-10,208	N/A	N/A	N/A
Free Cash Flow	-5,961	10,619	-2,660	0	0